IT8220069A0 - Metodo per impedire il deposito di grasso del corpo nei mammiferi. - Google Patents

Metodo per impedire il deposito di grasso del corpo nei mammiferi.

Info

Publication number
IT8220069A0
IT8220069A0 IT8220069A IT2006982A IT8220069A0 IT 8220069 A0 IT8220069 A0 IT 8220069A0 IT 8220069 A IT8220069 A IT 8220069A IT 2006982 A IT2006982 A IT 2006982A IT 8220069 A0 IT8220069 A0 IT 8220069A0
Authority
IT
Italy
Prior art keywords
mammals
deposit
preventing
body fat
fat
Prior art date
Application number
IT8220069A
Other languages
English (en)
Other versions
IT1152769B (it
Inventor
Ronald T Stanko
Original Assignee
Montefiore Hospital & Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montefiore Hospital & Medica filed Critical Montefiore Hospital & Medica
Publication of IT8220069A0 publication Critical patent/IT8220069A0/it
Application granted granted Critical
Publication of IT1152769B publication Critical patent/IT1152769B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
IT20069/82A 1981-04-01 1982-03-10 Metodo per impedire il deposito di grasso del corpo nei mammiferi IT1152769B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/249,812 US4351835A (en) 1981-04-01 1981-04-01 Method for preventing body fat deposition in mammals

Publications (2)

Publication Number Publication Date
IT8220069A0 true IT8220069A0 (it) 1982-03-10
IT1152769B IT1152769B (it) 1987-01-14

Family

ID=22945115

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20069/82A IT1152769B (it) 1981-04-01 1982-03-10 Metodo per impedire il deposito di grasso del corpo nei mammiferi

Country Status (6)

Country Link
US (1) US4351835A (it)
JP (2) JPS57175117A (it)
AU (1) AU552442B2 (it)
BE (1) BE891655A (it)
FR (1) FR2502953B1 (it)
IT (1) IT1152769B (it)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645764A (en) * 1981-04-01 1987-02-24 Montefiore Hospital Method for preventing body fat deposition in animals
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
US4812479A (en) * 1981-04-01 1989-03-14 The Montefiore Hospital Society Of Western Pennsylvania, Inc. Method for preventing body fat deposition in mammals
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
USRE38604E1 (en) * 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
US4818543A (en) * 1987-10-15 1989-04-04 University Of Georgia Research Foundation, Inc. Control of food intake in poultry by dietary addition
US4874790A (en) * 1988-08-15 1989-10-17 Montefiore Hospital Association Of Western Pennsylvania Method for improving the glucose metabolism of an animal having diabetic tendencies
US5134162A (en) * 1990-12-24 1992-07-28 The Montefiore Hospital Association Of Western Pennsylvania Method for lowering high blood cholesterol levels in hyperlipidemic animals and confections as the ingestion medium
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5403921A (en) * 1993-04-30 1995-04-04 University Of New Mexico Exercise hydration regimen to enhance exercise endurance and performance
US5612374A (en) * 1994-02-14 1997-03-18 Ronald T. Stanko Inhibiting growth of mammary adenocarcinoma
US5480909A (en) * 1994-08-08 1996-01-02 University Of Pittsburgh Medical Center Method for inhibiting generation of free-radicals
US5801198A (en) * 1995-07-13 1998-09-01 University Of Pittsburgh Medical Center Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
AU719332B2 (en) * 1995-09-19 2000-05-04 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US5886040A (en) * 1997-06-17 1999-03-23 Amt Labs, Inc. Creatine pyruvate salt with enhanced palatability
US6177576B1 (en) 1997-08-05 2001-01-23 Michael J. Arnold Pyruvate saccaride ketals
US5876763A (en) * 1998-05-26 1999-03-02 University Of New Mexico Glycerol enhanced rehydration formulation
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
EP1372641A4 (en) 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
EP1494659B1 (en) * 2002-04-17 2005-10-12 Critical Therapeutics, Inc. Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
FR2863620B1 (fr) * 2003-12-16 2007-05-25 Roquette Freres Utilisation d'au moins un cetose de 3 a 5 atomes de carbone comme substitut d'agents reticulants de proteines
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
US7947736B2 (en) 2004-07-16 2011-05-24 Btg International Limited Oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
US20070281892A1 (en) * 2004-09-21 2007-12-06 Martin Keith F Dopaminergic Mimetics
WO2006098767A2 (en) * 2004-09-21 2006-09-21 Ketocytonyx Inc. Treatment of adhd
US20100047221A1 (en) * 2006-04-12 2010-02-25 Alexander Ranya L Compositions comprising pyruvate alkyl esters and uses thereof
US9596872B2 (en) 2009-01-16 2017-03-21 Hill's Pet Nutrition, Inc. Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof
CN102665704A (zh) * 2009-12-29 2012-09-12 希尔氏宠物营养品公司 用于伴侣动物的包含丙酮酸盐的组合物及其使用方法
US20200237815A1 (en) 2017-02-24 2020-07-30 Alain Martin Methods for treatment of lung damage and for inhibition of lung fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver

Also Published As

Publication number Publication date
FR2502953A1 (fr) 1982-10-08
AU552442B2 (en) 1986-05-29
BE891655A (fr) 1982-04-16
US4351835A (en) 1982-09-28
AU8161282A (en) 1982-10-07
JPH0363531B2 (it) 1991-10-01
JPS57175117A (en) 1982-10-28
FR2502953B1 (fr) 1986-07-25
JPH04352718A (ja) 1992-12-07
IT1152769B (it) 1987-01-14

Similar Documents

Publication Publication Date Title
IT8220069A0 (it) Metodo per impedire il deposito di grasso del corpo nei mammiferi.
IT8220600A0 (it) Disposizione di vagli nella vasca di scarico di lavastoviglie.
IT1153307B (it) Raccordo per catetere
IT1147559B (it) Perfezionamento nei trasduttori ultrasonici in particolare per la vaporizzazione del combustibile in
ES513365A0 (es) Mejoras introducidas en un conjunto de cateter intravenoso.
RO81489A (ro) Instalatie mobila si procedeu de curatarea patului de balast al cailor ferate
DE3280388D1 (de) Einstellbare schiene.
IT8124141A0 (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
ES522754A0 (es) Procedimiento de obtener alcaloides del tipo de la berberina y similares.
IT1167647B (it) Perfezionamento nei cateteri con valvola
IT8124574A0 (it) Procedimento per la preparazione ela separazione di metil ter-butiletere.
IT8247744A0 (it) Perfezionamento nei carburatori
IT8123195A0 (it) Procedimento per la preparazione di metil ter-butil etere e di etilter-butil etere.
IT8219344A0 (it) Procedimento e dispositivo per lapreparazione di blocchi muniti di placcatura.
IT1157058B (it) Procedimento per la preparazione di acril e metaacrilamidi n.sostituite
IT8122488V0 (it) Sedile per gabinetto.
NL190613B (nl) In water gedispergeerde bekledingssamenstelling.
IT8148939A0 (it) Perfezionamento nei sistemi per l'i solamento di forni industriali
NO823892L (no) Gulvsluk.
IT8184117A0 (it) Complesso di elementi strutturali per la formazione di mobili componibili.
IT1148374B (it) Perfezionamento nelle rastrelliere di ordito
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.
IT8125583A0 (it) Procedimento per l'estrazione di brodi di fermentazione nonfiltrati.
IT1189400B (it) Procedimento per eliminare le screpolature nel sapone
IT8224536A0 (it) Procedimento di preparazione di mononitroclorobenzene.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329